Evidence suggests that topiramate (Topamax)is a teratogen.

Question

Quizplus · Accepted Answer

There is evidence to suggest that topiramate (Topamax) is a teratogen, meaning it has the potential to cause birth defects in fetuses when taken during pregnancy. The FDA has classified it as a pregnancy category D drug, meaning there is positive evidence of human fetal risk. It is important for women of childbearing age to discuss the risks and benefits of topiramate with their healthcare provider before starting treatment.

Evidence Suggests That Topiramate (Topamax)is a Teratogen